Mosaic Co (MOS) Q1 2026 Earnings Call Transcript

Why It Matters

Mosaic’s operational resilience and aggressive cost discipline position it to navigate margin pressure while scaling a high‑margin biosciences platform, supporting debt reduction and potential shareholder returns.

Key Takeaways

• North America sales outperformed market decline
• Phosphate production 7M‑ton target for 2026
• Cost savings $150M achieved, $100M planned
• Sulfur price spike compresses margins through 2026
• Biosciences aims to double sales again

Pulse Analysis

Mosaic’s Q1 2026 earnings call highlighted a nuanced market backdrop where U.S. phosphate demand softened in late 2025 but began to recover ahead of the spring planting season. The company leveraged this window to capture market share, especially in North America, where sales volumes rose despite broader declines in potash and phosphate shipments. Production metrics underscore the recovery: 1.7 million tons produced in Q4 and a firm commitment to reach at least 7 million tons of phosphate in 2026, while potash output is projected to hold steady near 9 million tons, matching the previous year’s record levels.

Cost efficiency remains a cornerstone of Mosaic’s strategy. The firm announced $150 million of cost savings realized ahead of schedule in 2025, driven by mine optimization, labor reductions, and supplier consolidation, and it targets an additional $100 million in 2026. However, a late‑year sulfur price spike threatens to erode margins across the Phosphates and Mosaic Fertilizantes segments, prompting temporary idling of low‑margin Brazilian assets. Working capital pressures added $960 million to cash‑flow use, inflating net debt, but management expects a $300‑$500 million release as inventories normalize, improving EBITDA‑to‑cash conversion toward historic 70% levels.

Growth prospects are anchored by Mosaic Biosciences, which doubled 2025 net sales to $68 million with gross margins in the 40% range and plans to replicate that growth in 2026 through new product launches and expanded registrations in 16 countries. Asset divestitures, including the pending Carlsbad sale, will free up roughly $170 million and cut retirement obligations, reinforcing the company’s balance sheet. With CapEx set at $1.5 billion for essential maintenance and regulatory projects, Mosaic aims to sustain free cash flow above dividend requirements, positioning itself for debt reduction and potential extraordinary shareholder returns once margin recovery materializes.